Literature DB >> 16785203

Rectal Epstein-Barr virus-positive Hodgkin's lymphoma in a patient with Crohn's disease: case report and review of the literature.

Maria Bai1, Konstantinos H Katsanos, Michael Economou, Sevasti Kamina, Christine Balli, Evangelos Briasoulis, Angelos M Kappas, Niki Agnantis, Epameinondas V Tsianos.   

Abstract

We present the case of a 35-year-old man with Crohn's disease diagnosed at the age of 27, several months after an operation for small-bowel adenocarcinoma. Seven years after the adenocarcinoma diagnosis, the patient presented with severe continuous anal pain and diarrhea. In parallel with antibiotic administration, the patient was given treatment with Infliximab, but without clinical symptom amelioration. Sigmoidoscopy and subsequent biopsies from an ulcerated rectal area supported the diagnosis of Epstein-Barr virus-positive (EBV+) primary Hodgkin's lymphoma. Infliximab administration was immediately discontinued and the patient underwent oncological follow-up and began a course of chemotherapy. Only a few cases with primary gastrointestinal Hodgkin's lymphoma in Crohn's disease patients have so far been reported, including a variety of scenarios on the causal relationship including disease duration, presence of EBV, long-term immunosuppressive treatment and, recently, anti-TNFalpha administration.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16785203     DOI: 10.1080/00365520500529629

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  7 in total

1.  Sources of information on lymphoma associated with anti-tumour necrosis factor agents: comparison of published case reports and cases reported to the French pharmacovigilance system.

Authors:  Hélène Théophile; Thierry Schaeverbeke; Ghada Miremont-Salamé; Abdelilah Abouelfath; Valentine Kahn; Françoise Haramburu; Bernard Bégaud
Journal:  Drug Saf       Date:  2011-07-01       Impact factor: 5.606

2.  Contribution of the 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography to the diagnosis of primary osseous Hodgkin lymphoma.

Authors:  Florence Breibach; Anne Julian; Camille Laurent; Eric Anglade; Arnaud Constantin; Nicolas Sans; Jean-Louis Tricoire; Pierre Brousset; Marie-Bernadette Delisle; Anne Gomez-Brouchet
Journal:  BMJ Case Rep       Date:  2009-05-25

3.  Incidence, clinical characteristics, and natural history of pediatric IBD in Wisconsin: a population-based epidemiological study.

Authors:  Tonya Adamiak; Dorota Walkiewicz-Jedrzejczak; Daryl Fish; Christopher Brown; Jeanne Tung; Khalid Khan; William Faubion; Roger Park; Janice Heikenen; Michael Yaffee; Maria T Rivera-Bennett; Marcy Wiedkamp; Michael Stephens; Richard Noel; Melodee Nugent; Justin Nebel; Pippa Simpson; Michael D Kappelman; Subra Kugathasan
Journal:  Inflamm Bowel Dis       Date:  2013-05       Impact factor: 5.325

4.  A new subtype of Hodgkin's lymphoma, syncytial nodular sclerosing: first case report of primary small bowel lymphoma.

Authors:  Anh T Nguyen; Shahreyar Hashemi; Michael R Castellano; Michael Eisenbraun; Gene F Coppa
Journal:  J Gastrointest Cancer       Date:  2009

Review 5.  Lymphoproliferative disorders in inflammatory bowel disease patients on immunosuppression: Lessons from other inflammatory disorders.

Authors:  Grace Y Lam; Brendan P Halloran; Anthea C Peters; Richard N Fedorak
Journal:  World J Gastrointest Pathophysiol       Date:  2015-11-15

6.  A Burkitt's Lymphoma Case Mimicking Crohn's Disease: A Case Report.

Authors:  Gulbanu Erkan; Mehmet Coban; Aysun Calıskan; Gokçe Kaan Ataç; Kamil Gulpınar; Bulent Degertekin; Atilla Korkmaz
Journal:  Case Rep Med       Date:  2011-09-08

7.  Pulmonary hodgkin lymphoma in a patient with Crohn's disease.

Authors:  Jae-Young Park; Juhie Lee
Journal:  Korean J Pathol       Date:  2014-10-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.